Healthcare
PRODUCTS
-
Natoli Scientific’s preclinical stability studies represent a critical facet of our pharmaceutical testing services, providing essential data on the shelf life and storage conditions of drug candidates. These studies are expertly designed to evaluate physical, chemical, and microbiological stability, ensuring that formulations retain their safety, efficacy, and quality over time. Our state-of-the-art facilities simulate various environmental conditions to scrutinize the integrity of products under stress-testing scenarios. The results gleaned from our stability studies guide the development of robust drug formulations and packaging, aid in regulatory submissions, and lay the groundwork for successful commercialization.
-
In such a highly regulated environment, change is not undertaken lightly. As a result, a lack of internal resources can often obstruct the implementation of change.
-
Enabling organizations of all sizes to transform their business through better use of technology.
-
Pharmaceutical labeling and kitting are critical for ensuring drug safety, compliance, and efficiency. Explore advanced technology and regulatory adherence to streamline these processes.
-
Single-use, automated filtration system designed to deliver robust process control during the clarification/harvest step.
WHITE PAPERS AND CASE STUDIES
-
Oligonucleotide Synthesis: Scale-Up Made Simple
Scaling oligonucleotide synthesis isn't as straightforward as it seems. Explore key challenges, critical process parameters, and solutions for a smooth scale-up.
-
Advancing QC Efficiency With SEC-MALS System And Empower Software
Discover how integration transforms lab workflows to enhance molecular characterization, streamline data management, and ensure compliance for superior data integrity and operational efficiency.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Trial Rescue: Leadership Approach To Propel Clinical Development
Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.
-
Achieving Self Sufficiency In Data Collection For Optinose
Uncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.
-
Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration
Learn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.
-
Pharma Company Digitizes Paper Logbooks To Increase Data Accessibility
A top pharma producer modernized its operations by digitizing paper-based logbooks. Discover how this shift supports compliance and scalability across global manufacturing environments.
-
Cell Collection Basics For The Transplant And CGT Industries
Breakthroughs in CAR T-cell and stem cell therapies depend on mastering cellular collection. Understanding these fundamentals is vital for advancing treatment efficacy and patient outcomes.
-
Creating Sustainable Data In The Laboratory
In a laboratory setting, data is everywhere. Learn in-depth about data challenges, the importance of data lifecycle management in laboratories, and the need for data sustainability.
-
Escondido, CA Uses Cityworks And Esri's ArcGIS® For Its Asset Management System
Read about water utility managers who took advantage of an offer from Trimble to do a pilot program for creating a ‘system of action’ that focuses on leveraging their investment in Esri’s ArcGIS® and water sensor data, location intelligence, and analytics tools.
-
Streamlining Global Respiratory Trial Complexities With Robust Data Capture Strategy
Want to see how eCOA solutions can simplify patient-reported data capture and accelerate global trials? Explore implementation strategies, lessons learned, and measurable results.
-
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection
Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
NEWS
-
Citizen Health Joins Forces With UCB To Accelerate Drug Development Across Epilepsy And Rare Diseases12/2/2025
Citizen Health today announced a new strategic partnership with UCB, a global biopharmaceutical leader in neurological and autoimmune research and development. The multi-year collaboration launches with a focus on epilepsy and five rare disease indications.
-
Integrated Photonics Spotlight: Innovations In Sensing And Environmental Monitoring7/14/2025
When disaster strikes slowly, we often fail to see it coming. The air doesn’t turn deadly overnight. Crops don’t fail in a day. But without precise, real-time environmental sensing, we miss the tipping points until it’s too late.
-
Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift8/11/2025
Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined the company as Chief Medical Officer. Dr. Mack, who previously served in this role from 2017 to 2021, brings renewed focus to aligning artificial intelligence (AI) with the future of regulatory compliance and clinical trial execution.
-
HealthEx Launches Platform To Empower Patients With Real-Time Health Record Access In Collaboration With Industry Leaders8/12/2025
HealthEx today launched its platform to enable patients to access, retrieve, and share their health records in real time, leveraging Individual Access Services (IAS) under the federal TEFCA™ framework.
-
AmpliTech Group Announces Innovative True 5G Technology Development2/20/2025
AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced, it is setting the record straight on what constitutes True 5G and how its revolutionary technology is paving the way for the future of wireless connectivity.